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The national incidence of neonatal abstinence syndrome has dramatically increased over the last decade due to an increase in 
antenatal opioid exposure. Recent human and animal studies suggest that antenatal opioid exposure impacts the developing 
brain. The purpose of this study is to evaluate the effects of perinatal methadone exposure on myelination in multiple regions 
in the developing rat brain. Pregnant Sprague-Dawley rats were randomly assigned into three experimental groups and 
subsequently exposed to drinking water alone or drinking water containing methadone from 7 days post coitum through day 
7 or through day 19 after delivery. Two male neonatal rats were randomly selected from each litter and terminated at day 19. 
The cerebral cortex, hippocampus, cerebellum, and brainstem were dissected and analyzed for three myelin specific proteins 
– CNP, PLP, and MBP – by Western blot analysis. All pups with exposure to methadone demonstrated decreased expression of 
CNP, PLP, and MBP in the cerebral cortex and hippocampus. In the cerebellum, PLP expression was down-regulated without 
apparent alteration of CNP and MBP expression. PLP and MBP expression, but not CNP expression, were significantly inhibited 
in the brainstem. Compared to the pups with postnatal methadone exposure via maternal milk through day 7, partial recovery 
of CNP and PLP expression only occurred in the cerebral cortices of the pups exposed through day 19. The findings show that 
antenatal opioid exposure in rat pups is associated with regionally-specific alterations in brain myelination that diversely affects 
myelin proteins. 
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INTRODUCTION
The medical and non‑medical use of opioids has in‑
creased exponentially over the last decade in women 
of childbearing age (Centers for Disease Control and 
Prevention, 2016). An increase in antenatal exposure to 
opioids has resulted in a greater than 5‑fold rise in the 
national incidence of neonatal abstinence syndrome 
(NAS) (Winkelman et al., 2018). A retrospective analysis 
of infants covered by Medicaid across the United States 
demonstrated an escalation in incidence of NAS from 
2.8/1000 live births in 2004 to 14.4/1000 live births in 
2014 (Winkelman et al., 2018).
The developmental impact of antenatal opioid expo‑
sure remains poorly delineated, but recent human and 
animal studies provide insight into the influence of ante‑
natal exposure on the structure of the developing brain. 
Walhovd et al. (2007) utilized MRI imaging to demon‑
strate that infants with exposure to illicit psychotropic 
polysubstances, including heroin during pregnancy, had 
smaller brain volumes, including white matter volumes, 
than those not exposed. Additional studies employing 
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MRI imaging found that infants with antenatal exposure 
to opioids (e.g., medication assisted treatment (MAT) with 
methadone and buprenorphine and illicit opioids such 
as heroin) and other psychotropic drugs had decreased 
whole brain volumes when compared to unexposed in‑
fants (Yuan et al., 2014) and that altered maturation of 
cerebral connective tract development may accompany in 
utero methadone exposure (Walhovd et al., 2012). 
Rat model data remains inconclusive regarding 
methadone effects on myelination. Rat pups with ante‑
natal exposure to methadone via an osmotic minipump 
implanted in the pregnant dam demonstrated an 
up‑regulation of myelin production and altered struc‑
ture (Vestal‑Laborde et al., 2014). Alternatively, rat 
pups with antenatal exposure to methadone via drink‑
ing water demonstrated decreased expression of my‑
elin‑specific proteins (Gourevitch et al., 2016). 
Detoxification during pregnancy has been associat‑
ed with high rates of relapse, extreme maternal stress, 
and possible harm to the fetus. Therefore, MAT with 
methadone or buprenorphine, is recommended by the 
American College of Obstetrics and Gynecology (ACOG) 
for treatment of women with opioid addiction during 
pregnancy (ACOG Committee, 2012). The purpose of 
this pilot study was to evaluate the effects of passive 
antenatal and passive postnatal methadone exposure 
via maternal milk on myelin development in various 
regions of the rat brain. 
METHODS
Animals
Twelve‑week‑old male and female Sprague‑Dawley 
rats (Charles River Laboratories, Wilmington, MA) were 
housed with food and water available ad libitum in an 
animal facility maintained at a temperature (22±2°C) 
and in a light‑controlled environment with an alter‑
nating 12‑hour light/dark cycle. All procedures were 
supervised by the University of Louisville Research Re‑
sources Center and an Association for Assessment and 
Accreditation of Laboratory Animal Care approved fa‑
cility and performed in accordance with the guidelines 
of the Animal Care and Use Committee of University of 
Louisville School of Medicine and NIH requirements for 
care and use of laboratory animals. 
Experimental groups and perinatal methadone 
(MTD) exposure model
Female rats were mated with a male rat and con‑
firmed for insemination. Neural development and 
myelination of the rat brain at postnatal day 7 (p7) is 
roughly equal developmentally to a full‑term human 
baby (Clancy et al., 2001; 2007). Then, nine pregnant 
rat dams were randomly assigned into three experi‑
mental groups (Fig. 1): dams exposed to drinking wa‑
ter alone (Control); dams exposed to drinking water 
containing MTD from 7 days post‑coitum (E7) to P7 
(MTD E7‑P7). To avoid abnormal nursing behaviors 
in the dams due to MTD withdrawal, the rat dams 
with MTD drinking water were replaced by lactating 
rats with drinking water alone; and dams exposed to 
drinking water containing MTD from E7 to P19 (MTD 
E7‑P19). Ten neonatal pups each from litter were re‑
tained at birth to eliminate variation in growth due to 
the differences in litter size. For rat pups born to dams 
in different MTD‑exposed groups, MTD exposure was 
maintained via placenta antenatally and via breast 
milk postnatally. 
During pregnancy, an increase in human daily oral 
dose of MAT may be required due to rapid clearance of 
MTD. Since a dose of 3 mg/kg body weight per day has 
not been shown to disrupt pregnancy in rats (Pierce et 
al., 1992; Daly et al., 2012), assuming a body weight of 
400 g, the pregnant dam was provide with 0.2 ml MTD 
(150 mg/ml) diluted in 1 liter drinking water based on 
daily water intake ad libitum (40 ml) (Atherton et al., 
1982). This dose is roughly equivalent to the maximum 
day 1 dose of MAT (40 mg) based on an average weight 
of 75 kg for American women following the extrapola‑
tion of dose between species published previously (Nair 
and Jacob, 2016), and did not result in global growth 
retardation in MTD‑exposed pups until P19. 
Tissue processing
Rodent white matter development exhibits a sexu‑
al dimorphism (Yang et al., 2008; Cerghet et al., 2009) 
probably due to different levels of steroid hormones 
(Jung‑Testas and Baulieu, 1998). The expression of my‑
elin‑specific proteins, including 2’,3’‑cyclic nucleotide 
3’‑phosphodiesterase (CNP), proteolipid protein (PLP), 
Fig.  1. Experimental workflow for perinatal MTD exposures and group 
assignment. 
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and myelin basic protein (MBP), showed increased ele‑
vation in males compared with females independent of 
strain and species (Cerghet et al., 2006). Thus, six male 
rats (two rats per litter) in each experimental group 
were anesthetized with isoflurane and decapitated at 
P19, as the maximal rate of myelin accumulation oc‑
curs at this age (Doretto et al., 2011). The whole brain 
was rapidly removed from the skull into a chamber 
perfused with chilled artificial cerebrospinal fluid con‑
taining (in mM) 128 NaCl, 3 KCl, 1.4 CaCl2, 1 MgSO4, 
21 NaHCO3, 0.5 NaH2PO4, and 30 glucose, equilibrated 
with 95% O2‑5% CO2. Four regions (cortex, hippocam‑
pus, cerebellum, and brain stem) were dissected out on 
ice for protein preparation. 
Western blots
Protein samples were prepared in CelLytic™ MT 
Cell Lysis Reagent (Sigma‑Aldrich, St. Louis, MO) 
containing the complete protease inhibitors (Roche, 
Indianapolis, IN) on ice. Western blots were per‑
formed as described previously (Cai et al., 2012; Wang 
et al., 2018). Equivalent amounts of total protein 
(30 μg/lane) were separated using 10% SDS‑polyacryl‑
amide gels (Bio‑Rad, Hercules, CA) and then electro‑
metrically transferred onto nitrocellulose membranes 
(Protan BA83, Midwest Scientific, Valley Park, MO). 
After blocking in 5% fat‑free milk for one hour to re‑
duce non‑specific antibody binding, the membranes 
were incubated overnight at 4°C with the following 
primary antibodies: mouse anti‑PLP (1:2000; Calbio‑
chem), rabbit anti‑MBP (1:3000; Millipore), mouse 
anti‑CNPase (1:4000; Millipore), and mouse anti‑β‑ac‑
tin (1:5000; Sigma‑Aldrich). After three washes, the 
membranes were incubated with corresponding 
horseradish peroxidase (HRP)‑conjugated secondary 
antibodies (1:3000; Santa Cruz) for one hour. The im‑
munoblots were visualized using ECL western blotting 
detection reagent (Pierce, Grand Island, NY). The opti‑
cal density (OD) of the protein bands was analyzed us‑
ing the BIO‑RAD ChemiDocTM Touch Imaging System 
(BIO‑RAD, Hercules, CA). The ODs for specific proteins 
were normalized to the corresponding β‑actin levels, 
and these values were expressed as the ratio relative 
to the control. An investigator who was masked to the 
group assignment performed the analysis. 
Statistical analysis
Data are presented as mean ± standard deviation 
(SD). Comparisons between three experimental groups 
were conducted using one‑way analysis of variance 
(ANOVA) followed by post‑hoc Tukey’s test using Graph‑
Pad Prism 5.0 (GraphPad Software, San Diego California 
USA). The significance level was p<0.05.
RESULTS
Opposite responses in myelin protein synthesis 
after perinatal MTD exposure in immature and 
mature oligodendrocytes in brain stem 
The expression levels of myelin specific proteins 
(CNP, PLP, and MBP) were measured and compared to 
those of the control group to identify alterations in 
myelin development after MTD exposure. CNP is lo‑
calized in immature oligodendrocytes, while PLP and 
MBP are synthesized in mature oligodendrocytes. Af‑
ter dams were exposed to MTD from either E7–P7 or 
Fig. 2. Representative Western blots (A) and statistical analysis (B) of myelin specific proteins CNP, PLP, and MBP in brainstems dissected from control 
and perinatal MTD-exposed rat pups. The data were presented as mean ± SD values and analyzed by one-way ANOVA followed by post-hoc Tukey’s test. 
* represents p<0.05 vs. control; n=6 pups randomly selected from 3 dams per group, respectively. 
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E7–P19, pups showed a significant decrease in PLP and 
MBP expression (p<0.001 vs. control, n=6) but an in‑
creasing trend in the expression of CNP in brainstem 
(p=0.066 vs. control, n=6). However, no statistical dif‑
ference was observed between the two MTD exposure 
groups (Fig. 2). 
Suppression of PLP expression after perinatal 
MTD exposure in the cerebellum
In the cerebellum, significant decreases in PLP ex‑
pression were observed in both groups of perinatally 
MTD‑exposed pups (E7–P7 and E7–P19) when compared 
to controls (p<0.001 vs. control, n=6). PLP expression in 
both groups of MTD‑exposed pups was not significant‑
ly different. Surprisingly, differences in the expression 
levels of MBP and CNP for all three groups did not reach 
significance (p>0.05 vs. control, n=6) (Fig. 3).
Marked reduction of expression of myelin 
proteins in cerebral cortex and hippocampus 
after perinatal exposure to MTD 
As shown in Fig. 4, expression levels of all three my‑
elin proteins were significantly decreased in cerebral 
cortices after perinatal MTD exposures from either E7– 
P7 or E7–P19 (CNP and PLP: p<0.001 vs. control; MBP: 
p<0.05 vs. control; n=6). Moreover, CNP and PLP syn‑
thesis seemed to be more vulnerable to perinatal MTD 
exposures than MBP. Similarly, dramatic decreases of 
the three myelin proteins were observed in the hippo‑
campus after perinatal MTD exposure (Fig. 5, p<0.001, 
Fig. 3. Representative Western blots (A) and statistical analysis (B) of myelin specific proteins CNP, PLP, and MBP in cerebella dissected from control and 
perinatal MTD-exposed rat pups. The data were presented as mean ± SD values and analyzed by one-way ANOVA followed by post-hoc Tukey’s test. 
*** represents p<0.001 vs. control; n=6 pups randomly selected by 2 pups per litter from 3 dams for each group, respectively. 
Fig. 4. Representative Western blots (A) and statistical analysis (B) of myelin specific proteins CNP, PLP, and MBP in cerebral cortices dissected from control 
and perinatal MTD-exposed rat pups. The data were presented as mean ± SD values and analyzed by one-way ANOVA followed by post-hoc Tukey’s test. 
* represents p<0.05, *** represents p<0.001 vs. control or MTD (E7-P7); n=6 pups randomly selected by 2 pups per litter from 3 dams for each group, 
respectively. 
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n=6). Taken together, perinatal MTD exposure induced 
severe impairments of myelin protein synthesis in re‑
gions of cerebral cortex and hippocampus.
DISCUSSION
MTD is the gold standard for treatment of opioid de‑
pendency during pregnancy (Farid et al., 2008). Treat‑
ment with MTD, a full opioid agonist, during pregnancy 
has been shown to improve multiple outcomes includ‑
ing compliance with obstetrical care, increased birth‑
weights, decreased neonatal death, and maintenance of 
custody with the biological parents at hospital discharge. 
Moderate to severe NAS is common in infants with ante‑
natal MTD exposure. Delineating the physiologic chang‑
es in the developing brain after antenatal exposure pro‑
vides a critical key to understanding long‑term develop‑
mental outcomes in this vulnerable population. 
The human brain undergoes rapid development in 
the first years of life, which includes accelerated my‑
elination from birth until three years of age. Myelin 
development then continues throughout the first de‑
cade of life. Distinct brain regions vary in their rate 
of myelin maturation (Carmody et al., 2004). Walhovd 
et al. (2012) demonstrated delayed and altered neural 
tract development using MRI with diffusion tensor 
imaging in infants with antenatal exposure to metha‑
done, which may underlie the increased risk for cogni‑
tive and behavioral difficulties in children. Gourevich 
et al. (2016), recently demonstrated results similar to 
ours with an overall trend of hypomyelination in brain 
stem when neonatal rat pups were exposed to MTD in 
utero and during the postnatal period, delivered by 
drinking water (3 mg/kg/day). Our study demonstrat‑
ed variable expression of immature (CNP) and mature 
(PLP and MBP) myelin proteins among the four brain 
regions of interest. In the brain stem, an increasing 
trend in CNP expression and significant decrease in 
PLP and MBP expression suggest an impairment of 
oligodendrocyte differentiation and/or myelin forma‑
tion with an impact on immature oligodendrocytes af‑
ter MTD exposure. Since µ‑opioid receptor activation 
stimulates oligodendrocyte proliferation (Knapp and 
Hauser, 1996; Vestal‑Laborde et al., 2014), an increasing 
trend of CNP expression may reflect an increase in im‑
mature oligodendrocytes undergoing differentiation. 
In the cerebellum, however, a significant decrease was 
only detected in PLP expression while CNP and MBP 
did not demonstrate differences when compared to the 
control group. In the cortex and hippocampus, expres‑
sion levels of CNP, PLP, and MBP were all significantly 
lower in MTD‑exposed groups, indicating impairments 
of both immature and mature oligodendrocytes. Our 
findings show that passive antenatal exposure to MTD 
has variable effects on myelination in different regions 
of the developing rat brain. Of note, compared to those 
pups exposed to MTD transferred through maternal 
breast milk for seven days, no difference or partial re‑
covery in the expression of myelin markers occurred 
in pups exposed to MTD for 19 days after birth, which 
suggests that in utero exposure to MTD may primarily 
contribute to myelin impairment whereas the impact 
of postnatal MTD exposure via breast milk is probably 
limited. 
The long‑term developmental consequences of 
perinatal opioid exposure remain largely unknown due 
to a lack of large longitudinal trials in this vulnerable 
population. A retrospective trial in 2018 found that 
children who were diagnosed and treated for NAS as 
infants demonstrated lower scores on the cognitive, 
language, and motor subscales of the Bayley Scales 
Fig. 5. Representative Western blots (A) and statistical analysis (B) of myelin specific proteins CNP, PLP, and MBP in hippocampi dissected from control 
and perinatal MTD-exposed rat pups. The data were presented as mean ± SD values and analyzed by one-way ANOVA followed by post-hoc Tukey’s test. 
*** represents p<0.001 vs control; n=6 pups randomly selected by 2 pups per litter from 3 dams for each group, respectively. 
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of Infant Development, 3rd Edition at two years of age 
when compared to national norms (Merhar et al., 2018). 
A recent Australian study (n=2,236) linked a discharge 
diagnosis of NAS with standardized test scores and 
found that the diagnosis of NAS was associated with 
lower mean standardized test scores in the 3rd, 5th, and 
7th grades and that the deficit was progressive (Oei et 
al., 2017). The mechanism for the developmental delays 
in children exposed to opioids in utero and in the post‑
natal period is not well delineated, although altered 
myelination has been proposed as a potential etiology 
(Vestal‑Laborde et al., 2014). Our study shows that pas‑
sive MTD exposure in utero and in the postnatal period 
through maternal breast milk is accompanied by hypo‑
myelination in cerebral cortex, hippocampus, brain‑
stem, and cerebellum in rat pups, which raises concern 
for similar effects in exposed infants.
There are several limitations to our study. This was 
a pilot study with a small sample size, hence the overall 
power to detect statistical significances is diminished. 
MTD dosage was based on prior accepted studies; how‑
ever, translating drug dosage from rats to humans is 
difficult given pharmacokinetic and drug metabolism 
differences. Lastly, the specific endpoints we used have 
been cited as approximations of rat to human myelin 
maturity. Closer review of the literature demonstrates 
that opinions vary.
In conclusion, our study supports the conjecture 
that passive exposure to MTD during the perinatal pe‑
riod is accompanied by altered CNS development. Giv‑
en the critical brain development that occurs from the 
time of conception through the first three years of life, 
altered myelination may contribute to neurodevelop‑
mental impairment. The impact of this significant pub‑
lic health concern deserves further study. 
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